ClinAmygate   Report issue

For profit Phase 4
Founded: Cairo Egypt (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2018
NCT03759301
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ClinAmygate

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ageusia (Phase 4)

Communicable Diseases (Phase 4)

Infections (Phase 4)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Olfaction Disorders (Phase 4)

Ovarian Hyperstimulation Syndrome (Phase 4)

Surgical Wound (Phase 4)

Surgical Wound Infection (Phase 4)

Syndrome (Phase 4)

Wound Infection (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 11